These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 5734763)

  • 1. [Biochemical findings in osteogenesis imperfecta].
    Mühlbach R
    Beitr Orthop Traumatol; 1968 Oct; 15(10):635-6. PubMed ID: 5734763
    [No Abstract]   [Full Text] [Related]  

  • 2. [Osteogenesis imperfecta tarda].
    Janssen G
    Z Orthop Ihre Grenzgeb; 1973 Aug; 111(4):592-3. PubMed ID: 4131007
    [No Abstract]   [Full Text] [Related]  

  • 3. Decrease of serum alkaline phosphatase after three cycles of pamidronate disodium in children with severe osteogenesis imperfecta.
    Cabral de Menezes Filho H; Rodrigues JM; Radonsky V; Della Manna T; Kuperman H; Steinmetz L; Dichtchekenian V; Damiani D; Setian N
    Horm Res; 2007; 68 Suppl 5():207-8. PubMed ID: 18174750
    [No Abstract]   [Full Text] [Related]  

  • 4. Enzyme histochemical localisation of alkaline phosphatase activity in osteogenesis imperfecta bone and growth plate: a preliminary study.
    Sarathchandra P; Cassella JP; Ali SY
    Micron; 2005; 36(7-8):715-20. PubMed ID: 16182549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma osteocalcin levels in patients with osteogenesis imperfecta.
    Castells S; Yasumura S; Fusi MA; Colbert C; Bachtell RS; Smith S
    J Pediatr; 1986 Jul; 109(1):88-91. PubMed ID: 3487629
    [No Abstract]   [Full Text] [Related]  

  • 6. Intravenous pamidronate treatment of children under 36 months of age with osteogenesis imperfecta.
    DiMeglio LA; Ford L; McClintock C; Peacock M
    Bone; 2004 Nov; 35(5):1038-45. PubMed ID: 15542028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in bone biochemical markers after high-dose cerivastatin treatment in a woman with osteogenesis imperfecta.
    Sugiyama T; Kawai S
    J Bone Miner Metab; 2001; 19(6):382-4. PubMed ID: 11685655
    [No Abstract]   [Full Text] [Related]  

  • 8. [Biochemical studies of the serum of an infant with osteogenesis imperfecta].
    Maszewska-Kuźniarz K; Lukas A; Lukas W
    Wiad Lek; 1972 Feb; 25(4):379-82. PubMed ID: 5061599
    [No Abstract]   [Full Text] [Related]  

  • 9. [A contribution to the clinical picture of osteogenesis imperfecta].
    Janke D
    Beitr Orthop Traumatol; 1968 Oct; 15(10):634-5. PubMed ID: 5734762
    [No Abstract]   [Full Text] [Related]  

  • 10. [Biochemical studies on osteogenesis imperfecta].
    Bethge JF; Tölke M; Wiesinger H
    Bruns Beitr Klin Chir (1971); 1967 Jun; 214(4):448-58. PubMed ID: 5593463
    [No Abstract]   [Full Text] [Related]  

  • 11. [Osteogenesis imperfecta with ketone hyperglycinemia, hyperserinemia and hyperornithinemia].
    Mechelany-Leroy L; Merckx J
    Nouv Presse Med; 1980 Jun; 9(26):1844. PubMed ID: 6771747
    [No Abstract]   [Full Text] [Related]  

  • 12. Serum acid phosphatase in osteogenesis imperfecta.
    JACOBSEN JG; MATIENZO JA; FORBES AP; ROURKE GM
    Metabolism; 1961 Jun; 10():483-8. PubMed ID: 13718588
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies of patients with osteogenesis imperfecta.
    Albright JA; Grunt JA
    J Bone Joint Surg Am; 1971 Oct; 53(7):1415-25. PubMed ID: 5114704
    [No Abstract]   [Full Text] [Related]  

  • 14. Vitamin D and related research in osteogenesis imperfecta.
    Sbyrakis S; Mengreli C; Côté GB; Morakis A
    Prog Clin Biol Res; 1982; 104():367-76. PubMed ID: 6298814
    [No Abstract]   [Full Text] [Related]  

  • 15. Cortical bone dynamics measured by means of tetracycline labeling in 21 cases of osteoporosis.
    Villanueva A; Frost H; Ilnicki L; Frame B; Smith R; Arnstein R
    J Lab Clin Med; 1966 Oct; 68(4):599-616. PubMed ID: 5923251
    [No Abstract]   [Full Text] [Related]  

  • 16. [On fragilitas ossium hereditaria or Lobstein's disease (observations on 2 cases)].
    Zappata A; Mazzi C
    Ann Laringol Otol Rinol Faringol; 1968; 67(1):50-61. PubMed ID: 5757201
    [No Abstract]   [Full Text] [Related]  

  • 17. Normal serum acid phosphatase levels in osteogenesis imperfecta.
    GINSBERG DM
    Ann Intern Med; 1962 Jan; 56():141-3. PubMed ID: 13898751
    [No Abstract]   [Full Text] [Related]  

  • 18. Alendronate treatment in osteogenesis imperfecta.
    Madenci E; Yilmaz K; Yilmaz M; Coskun Y
    J Clin Rheumatol; 2006 Apr; 12(2):53-6. PubMed ID: 16601536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D metabolism in osteogenesis imperfecta during calcitonin therapy.
    Nishi Y; Hyodo S; Yoshimitsu K; Sawano K; Yamaoka K; Seino Y; Usui T
    Pediatrics; 1984 Apr; 73(4):538-42. PubMed ID: 6546792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [OSTEOGENESIS IMPERFECTA CONGENITA. CLINICAL, PATHOLOGICAL AND HISTOCHEMICAL STUDY].
    SCHAJOWICZ F; LUBOVITSKY BL; ROSEMBERG L
    Arch Argent Pediatr; 1963; 59():73-9. PubMed ID: 14154215
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.